SOC Telemed to Provide Corporate and Financial Update for the Second Quarter 2021 on August 12, 2021
SOC Telemed, Inc. (NASDAQ: TLMD) announced a corporate and financial update for Q2 2021 set for August 12, 2021, after market close. The management team will host a conference call and audio webcast at 5:00 p.m. ET. Investors can join the call by dialing domestic (877) 870-4263 or international (412) 317-0790, with the passcode referencing the SOC Telemed call. SOC Telemed is a leader in acute telemedicine technology, providing solutions across multiple specialties.
- Leads the acute telemedicine sector, enabling sustainable telemedicine programs across clinical specialties.
- Maintained The Joint Commission's Gold Seal of Approval since inception.
- None.
RESTON, Va., July 29, 2021 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ: TLMD, "SOC"), the largest national provider of acute care telemedicine, today announced that the company will provide a corporate and financial update for the second quarter 2021, on Thursday, August 12, 2021, after market close. SOC Telemed's management team will host a conference call and live audio webcast at 5:00 p.m. ET.
To participate in the call, dial either the domestic or international number fifteen minutes before the conference call begins:
Domestic: (877) 870-4263
International: (412) 317-0790
Passcode: please reference the SOC Telemed call
The live conference call and replay can also be accessed via audio webcast at the Investor Relations section of the Company's website, located at SOC Telemed Investor Relations - Home.
About SOC Telemed
SOC Telemed (NASDAQ: TLMD, "SOC") is the leading national provider of acute telemedicine technology and solutions to hospitals, health systems, post-acute providers, physician networks, and value-based care organizations since 2004. Built on proven and scalable infrastructure as an enterprise-wide solution, SOC's technology platform, Telemed IQ, rapidly deploys and seamlessly optimizes telemedicine programs across the continuum of care. SOC provides a supportive and dedicated partner presence, virtually delivering patient care through teleNeurology, telePsychiatry, teleCritical Care, telePulmonology, teleCardiology, teleInfectious Disease, teleNephrology, teleMaternal-Fetal Medicine and other service lines, enabling healthcare organizations to build sustainable telemedicine programs across clinical specialties. SOC enables organizations to enrich their care models and touch more lives by supplying healthcare teams with industry-leading solutions that drive improved clinical care, patient outcomes, and organizational health. The company was the first provider of acute clinical telemedicine services to earn The Joint Commission's Gold Seal of Approval and has maintained that accreditation every year since inception. For more information, visit https://www.soctelemed.com/
Investor Relations:
Steve Rubis
Vice President, Investor Relations
SOC Telemed
P: (214) 681-7991
srubis@soctelemed.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/soc-telemed-to-provide-corporate-and-financial-update-for-the-second-quarter-2021-on-august-12-2021-301342531.html
SOURCE SOC Telemed
FAQ
When will SOC Telemed provide its Q2 2021 update?
What time is the SOC Telemed conference call?
How can I participate in the SOC Telemed conference call?
What is the ticker symbol for SOC Telemed?
Where can I find more information about SOC Telemed?
